Hemangini Patel joined Pfizer in June 2003. She has held several positions in manufacturing operations to support Prevenar vaccine production. Based at the Sanford site, she now manages daily operation of aseptic bulk filling and raw material dispensing. Part of her team is responsible for writing manufacturing investigations, document revisions and change controls. Her past experience includes working in operations to manufacture and test diagnostic kits for infectious disease like HIV, using Polymerase Chain Reaction) In her spare time she enjoys volunteering with Habitat for Humanity and "The Art of Living" foundation.
AMPATH is Kenya's most comprehensive model to provide quality health services to combat HIV and treat patients with other infectious and non-communicable diseases in Kenya. The program cares for more than 100,000 HIV-infected children and adults. In 2012, Hemangini will work with Academic Model Providing Access to Healthcare (AMPATH) to assess and increase the efficiency of the organization's drug management system to improve drug procurement, stock management, and integrity of the drug supply chain.
Through her Fellowship experience, Hemangini hopes to develop the ability to work in diverse environments with multi cultural teams and to gain new insights into the lives of people living in developing countries.
The Academic Model Providing Access to Healthcare (AMPATH) is a partnership between Kenya's Moi University School of Medicine, Moi Teaching and Referral Hospital, and a consortium of U.S. medical schools led by Indiana University. Providing both clinic- and community-based pharmacy services, the initiative addresses health care system barriers, like education and infrastructure, which prevent the dissemination of high-quality care in resource-deprived Kenya. AMPATH treats over 120,000 HIV-positive patients at 23 sites in both urban and rural Kenya.